[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"University of Novi Sad\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":129},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,4,0,[8,44,73,103],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":27,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":33,"lastUpdatePostDateStruct":34,"startDateStruct":37,"completionDateStruct":39,"leadSponsor":41,"locationsCount":4},"100626633","maternal-satisfaction-after-spinal-anesthesia-for-cesarean-delivery-100626633",false,"NCT07438171","Maternal Satisfaction After Spinal Anesthesia for Cesarean Delivery","Maternal Satisfaction Following Different Spinal Anesthesia Regimens for Elective Cesarean Delivery: a Prospective Observational Study","Inclusion Criteria: Parturients for elective cesarean delivery, ASA, status II and III, age between 18 and 45 years, singleton pregnancy, able to provide inform consent. -\n\nExclusion Criteria: Refuse to participate in the study, spinal anesthesia refused, known drug allergies to drugs included in the study, multiple pregnancy, preterm gestation, skin lesion at the beck, severe maternal comorbidities, chronic opioid use and chronic pain. -","FEMALE","18 Years","45 Years",{"count":20,"type":21},200,"ESTIMATED","OBSERVATIONAL","The goal of this observational study is to evaluate the impact of four different spinal anesthesia regimens on maternal satisfaction following cesarean delivery.\n\nThe main questions this study aims to answer are:\n\n* Primary outcome: Patient satisfaction with the provided analgesia during the first 24 hours postoperatively.\n* Secondary outcome: The need for rescue analgesics. Participants will complete a specially designed questionnaire 24 hours after cesarean delivery.",[25,26],"Parturients","Elective Cesarean Delivery",[28,29,30,31],"Maternal satisfaction","Spinal anesthesia","cesarean delivery","postcesarean analgesia","NOT_YET_RECRUITING","2026-02-22",{"date":35,"type":36},"2026-02-27","ACTUAL",{"date":38,"type":21},"2026-03-02",{"date":40,"type":21},"2026-09-01",{"name":42,"class":43},"University of Novi Sad","OTHER",{"id":45,"slug":46,"hasResults":11,"nctId":47,"briefTitle":48,"officialTitle":49,"acronym":50,"eligibilityCriteria":51,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":52,"enrollmentInfo":53,"targetDuration":4,"studyType":55,"phases":56,"briefSummary":58,"conditions":59,"keywords":62,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":64,"lastUpdatePostDateStruct":65,"startDateStruct":67,"completionDateStruct":69,"leadSponsor":71,"locationsCount":72},"100625696","fet-let-2x2-clinical-pregnancy-rates-after-frozen-embryo-transfer-in-natural-and-modified-natural-cycles-100625696","NCT07425990","FET-LET-2x2: Clinical Pregnancy Rates After Frozen Embryo Transfer in Natural and Modified Natural Cycles","FET-LET-2x2: A Randomized Open-Label 2×2 Factorial Trial Comparing Clinical Pregnancy Rates After Frozen Embryo Transfer in True and Modified Natural Cycles With and Without Aromatase Inhibitors","FET-LET-2x2","Inclusion Criteria:\n\n* Women aged 18 to 40 years\n* Regular menstrual cycles (26-35 days)\n* Scheduled for frozen embryo transfer (FET) in a natural menstrual cycle\n* Normal gynecological ultrasound findings without clinically significant uterine abnormalities\n* Ability to provide written informed consent\n\nExclusion Criteria:\n\n* Use of preimplantation genetic testing (PGT) for the transferred embryo\n* Use of donor oocytes\n* Inadequate embryo survival after thawing, defined as loss of viability in more than 50% of blastomeres\n* Irregular menstrual cycles\n* Presence of clinically significant uterine abnormalities detected by ultrasound\n* Inability or unwillingness to provide written informed consent","40 Years",{"count":54,"type":21},120,"INTERVENTIONAL",[57],"NA","The goal of this clinical trial is to learn whether different natural approaches to preparing the uterus for frozen embryo transfer (FET) can improve pregnancy success in women undergoing in vitro fertilization (IVF) treatment.\n\nThe main questions it aims to answer are:\n\n1. Is a completely natural menstrual cycle more successful than a natural cycle in which ovulation is triggered with medication when preparing for frozen embryo transfer?\n2. Does taking a medication called letrozole at the beginning of the cycle improve pregnancy success compared to not taking it?\n\nResearchers will compare four different approaches to see which one results in the highest chance of achieving a clinical pregnancy, confirmed by ultrasound.\n\nParticipants will:\n\n* Be randomly assigned to one of four groups\n* Undergo monitoring with ultrasound and blood hormone tests during their menstrual cycle\n* In some groups, take letrozole tablets for a few days early in the cycle\n* In some groups, receive a hormone injection to help control the timing of ovulation\n* Undergo frozen embryo transfer at the appropriate time\n* Receive standard hormonal support after embryo transfer\n* Researchers will compare four different approaches to see which one results in the highest chance of achieving a clinical pregnancy, confirmed by ultrasound.",[60,61],"Infertility Female","Frozen Embryo Transfer (FET)",[63],"Natural cycle FET","2026-02-16",{"date":66,"type":36},"2026-02-23",{"date":68,"type":21},"2026-02",{"date":70,"type":21},"2027-03",{"name":42,"class":43},1,{"id":74,"slug":75,"hasResults":11,"nctId":76,"briefTitle":77,"officialTitle":78,"acronym":79,"eligibilityCriteria":80,"healthyVolunteers":81,"sex":82,"minAge":17,"maxAge":4,"enrollmentInfo":83,"targetDuration":4,"studyType":55,"phases":85,"briefSummary":86,"conditions":87,"keywords":89,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":95,"lastUpdatePostDateStruct":96,"startDateStruct":98,"completionDateStruct":100,"leadSponsor":102,"locationsCount":4},"100600494","hydrogen-rich-water-and-resting-metabolism-in-young-adults-100600494","NCT07098221","Hydrogen-Rich Water and Resting Metabolism in Young Adults","Effects of Hydrogen-Rich Water on Resting Metabolism in Healthy Young Adults: A Randomized, Double-Blind, Placebo-Controlled Crossover Trial","H2REST","Inclusion Criteria:\n\n* Aged 18-35 years\n* BMI between 18.5 and 25.0 kg\u002Fm²\n* Apparently healthy, with no history of chronic disease\n* Non-smoker, not currently using nicotine-containing products\n* Able to provide informed consent\n* Willing to refrain from alcohol, caffeine, and strenuous exercise for 24 hours before each study visit\n* Able to comply with study procedures, including fasting and attending all study visits\n\nExclusion Criteria:\n\n* Diagnosed metabolic, cardiovascular, respiratory, gastrointestinal, or endocrine disorders\n* Use of dietary supplements or medications affecting metabolism (within the past 2 weeks)\n* Allergy or intolerance to components of the hydrogen or placebo beverages\n* Pregnant or lactating\n* Shift work or irregular sleep schedule\n* Participation in another clinical study within the past 30 days",true,"ALL",{"count":84,"type":21},24,[57],"The H2REST trial is a randomized, double-blind, placebo-controlled crossover study investigating the acute effects of a single dose of hydrogen-rich water (HRW) on resting metabolism in healthy young adults. Participants complete two testing sessions-receiving either HRW or placebo in a randomized order-followed by standardized metabolic testing. Primary outcomes include resting energy expenditure, respiratory exchange ratio, and substrate utilization measured via indirect calorimetry. The study aims to assess whether acute HRW intake can modulate metabolic rate and fuel preference at rest, and to explore inter-individual variability in response.",[88],"Healthy Subjects or Volunteers",[90,91,92,93,94],"Hydrogen-rich water","Resting metabolism","Energy expenditure","Substrate utilization","Metabolic rate","2025-07-24",{"date":97,"type":36},"2025-08-01",{"date":99,"type":21},"2025-09-01",{"date":101,"type":21},"2025-12-01",{"name":42,"class":43},{"id":104,"slug":105,"hasResults":11,"nctId":106,"briefTitle":107,"officialTitle":107,"acronym":4,"eligibilityCriteria":108,"healthyVolunteers":11,"sex":82,"minAge":17,"maxAge":4,"enrollmentInfo":109,"targetDuration":4,"studyType":55,"phases":110,"briefSummary":112,"conditions":113,"keywords":115,"overallStatus":120,"whyStopped":4,"lastUpdateSubmitDate":121,"lastUpdatePostDateStruct":122,"startDateStruct":124,"completionDateStruct":126,"leadSponsor":128,"locationsCount":72},"100504535","phase-3-dexmedetomidinine-in-the-prevention-of-postoperative-delirium-in-the-intensive-care-unit-after-cardiac-surgery-100504535","NCT05849597","Dexmedetomidinine in the Prevention of Postoperative Delirium in the Intensive Care Unit After Cardiac Surgery","Inclusion Criteria:\n\n* patients undergoing open heart surgery with the use of cardiopulmonary bypass (including coronary artery bypass grafting, valve repair\u002Freplacement, and combined)\n* left ventricular ejection fraction (LVEF) \\>40%.\n\nExclusion Criteria:\n\n* preoperative atrial fibrillation\n* previous history of interventionally treated arrhythmias\n* second and third degree atrioventricular block\n* bradycardia with heart rate ≤50\u002Fmin\n* pacemaker\n* renal or hepatic insufficiency\n* emergency procedures\n* history of serious mental illness, delirium, and severe dementia",{"count":20,"type":21},[111],"PHASE3","This is a prospective, randomized, single blinded, controlled clinical trial designed to compare the clinical effects of sedation with dexmedetomidine versus propofol in patients undergoing cardiac surgery.",[114],"Intensive Care Unit Delirium",[116,117,118,119],"open heart surgery","sedation","dexmedetomidine","postoperative delirium","RECRUITING","2024-12-03",{"date":123,"type":36},"2024-12-04",{"date":125,"type":36},"2022-03-01",{"date":127,"type":21},"2025-06",{"name":42,"class":43},""]